1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Checkpoint Therapeutics, Inc.

Checkpoint Therapeutics, Inc.

CKPT
Checkpoint Therapeutics, Inc.US flagNASDAQ Capital Market
4.26
USD
- -
- -
367.72MMarket Cap

Income Statement (USD)

APIChatGPT
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
As of date
12/31/2015
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
Sales/Revenue/Turnover
1
3
2
4
2
1
- -
- -
- -
- -
+ Sales & Services Revenue
1
3
2
4
2
1
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
-1
-3
-2
-4
-2
-1
- -
- -
- -
- -
- Operating Expenses
14
25
24
40
27
24
57
59
52
56
+ Selling, General & Admin
2
4
5
7
7
8
9
9
9
20
+ Research & Development
11
20
19
34
19
16
48
50
44
36
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-13
-22
-23
-37
-25
-23
-57
-58
-52
-56
- Non-Operating (Income) Loss
1
- -
- -
- -
- -
- -
- -
4
- -
- -
+ Interest Expense, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Interest Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
- -
- -
- -
4
- -
- -
Pretax Income
-14
-22
-23
-36
-25
-23
-57
-63
-52
-56
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-14
-22
-23
-36
-25
-23
-57
-63
-52
-56
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-14
-22
-23
-36
-25
-23
-57
-63
-52
-56
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-14
-22
-23
-36
-25
-23
-57
-63
-52
-56
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-14
-22
-23
-36
-25
-23
-57
-63
-52
-56
EBIT
-13
-22
-23
-37
-25
-23
-57
-58
-52
-56
EBITDA
-13
-22
-23
-37
-25
-23
-57
-58
-52
-56
EBITDA Margin (%)
-2,240.85
-862.41
-1,320.29
-1,047.92
-1,454.92
-2,170.35
-21,165.3
-30,381.77
-50,629.13
-137,009.76
EBITA
-13
-22
-23
-37
-25
-23
-57
-58
-52
-56
Gross Margin (%)
100
100
100
100
100
100
100
100
100
100
Operating Margin (%)
-2,240.85
-862.41
-1,320.29
-1,047.92
-1,454.92
-2,170.35
-21,165.3
-30,381.77
-50,629.13
-137,009.76
Profit Margin (%)
-2,354.58
-873.97
-1,314.61
-1,037.28
-1,446.96
-2,159.12
-21,145.52
-32,616.67
-50,336.89
-137,170.73
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
2
2
2
3
4
6
8
9
19
40
Basic EPS, GAAP
-5.69
-10.43
-10.03
-12.74
-7
-4.13
-7.45
-7.09
-2.77
-1.42
Basic EPS from Cont Ops
-5.69
-10.43
-10.03
-12.74
-7
-4.13
-7.45
-7.09
-2.77
-1.42
Diluted Weighted Avg Shares
2
2
2
3
4
6
8
9
19
40
Diluted EPS, GAAP
-5.69
-10.43
-10.03
-12.74
-7
-4.13
-7.45
-7.09
-2.77
-1.42
Diluted EPS from Cont Ops
-5.69
-10.43
-10.03
-12.74
-7
-4.13
-7.45
-7.09
-2.77
-1.42

Balance Sheet (USD)

APIChatGPT
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
As of date
12/31/2015
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
Total Current Assets
51
36
21
25
27
43
56
13
5
7
+ Cash, Cash Equivalents & STI
50
35
19
22
26
41
55
12
5
7
+ Cash & Cash Equivalents
50
35
19
22
26
41
55
12
5
7
+ ST Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
1
- -
2
- -
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
1
- -
2
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
2
1
1
2
1
1
- -
1
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Property, Plant & Equip, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Property, Plant & Equip
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Accumulated Depreciation
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Assets
51
36
21
25
27
43
56
13
5
7
+ Payables & Accruals
2
3
6
13
8
7
25
20
17
18
+ Accounts Payable
1
2
4
10
3
3
16
12
7
6
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
1
1
2
3
5
3
9
9
11
12
+ ST Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
- -
- -
- -
- -
- -
1
1
12
1
2
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
- -
- -
- -
1
1
12
1
2
Total Current Liabilities
2
4
6
13
8
7
26
33
18
20
+ LT Debt
2
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Borrowings
2
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
2
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Liabilities
4
4
6
13
8
7
26
33
18
20
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
57
65
72
105
136
174
223
241
298
350
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
57
65
72
105
136
174
223
241
298
350
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-14
-36
-59
-95
-120
-143
-200
-262
-314
-371
+ Other Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
46
32
15
12
19
35
30
-19
-13
-13
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
46
32
15
12
19
35
30
-19
-13
-13
Total Liabilities & Equity
51
36
21
25
27
43
56
13
5
7
Shares Outstanding
2
2
3
3
5
7
8
10
28
54
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Debt
-48
-35
-19
-22
-26
-41
-55
-12
-5
-7
Net Debt to Equity
-103.35
-108.61
-127.82
-186.3
-138.36
-115.24
-184.01
61.94
37.77
52.31
Tangible Common Equity Ratio
91.59
89.79
70.24
47.42
69.89
83.06
53.38
-146.6
-242.6
-168.99
Current Ratio
28.3
9.8
3.36
1.9
3.32
5.9
2.14
0.41
0.29
0.37
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
As of date
12/31/2015
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
+ Net Income
-14
-22
-23
-36
-25
-23
-57
-63
-52
-56
+ Depreciation & Amortization
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
11
11
6
5
6
8
11
10
7
24
+ Stock-Based Compensation
3
4
3
2
3
3
3
3
3
15
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
8
7
3
3
3
6
8
7
4
9
+ Chg in Non-Cash Work Cap
2
1
1
6
-3
-2
20
-5
-3
1
+ (Inc) Dec in Accts Receiv
- -
-1
- -
-1
2
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
-2
- -
1
-1
1
- -
1
- -
+ Inc (Dec) in Accts Payable
2
2
3
7
-5
-1
19
-4
-4
2
+ Inc (Dec) in Other
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-1
-10
-15
-26
-21
-17
-26
-58
-48
-31
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
-3
-3
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
-3
-3
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
51
1
- -
31
28
33
41
18
34
26
+ Increase in Capital Stock
51
1
- -
31
28
33
41
18
34
26
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
-3
-3
- -
- -
- -
- -
- -
- -
- -
- -
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
3
-3
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash From Debt
3
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
-3
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
- -
- -
- -
-2
-2
-2
-1
-3
7
7
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
54
-2
- -
29
25
31
40
15
40
33
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
50
-15
-16
3
4
15
14
-43
-7
2
EBITDA
-13
-22
-23
-37
-25
-23
-57
-58
-52
-56
EBITDA Margin (%)
-2,240.85
-862.41
-1,320.29
-1,047.92
-1,454.92
-2,170.35
-21,165.3
-30,381.77
-50,629.13
-137,009.76
Free Cash Flow
-4
-13
-16
-26
-21
-17
-26
-58
-48
-31
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-13
-15
-26
-21
-17
-26
-58
-48
-31
Free Cash Flow per Basic Share
-1.49
-6.09
-7.01
-9.04
-6.05
-2.96
-3.46
-6.51
-2.54
-0.78
Price/Free Cash Flow
- -
-25.38
-5.83
-2.01
-2.84
-8.94
-8.99
-0.78
-0.9
-4.08
Cash Flow to Net Income
0.08
0.44
0.68
0.71
0.86
0.72
0.46
0.92
0.92
0.55
Capital Expenditures
-3
-3
- -
- -
- -
- -
- -
- -
- -
- -